Patent · US Active

Combined remodeling control therapy and anti-remodeling therapy by implantable cardiac device

US7805193B2 · kind B2 · utility

71Cited by
66References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 13, 2007
Grant dateSep 28, 2010
Priority date
Expiry dateJul 7, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N1/36114
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A method and device for delivering ventricular resynchronization pacing therapy in conjunction with electrical stimulation of nerves which alter the activity of the autonomic nervous system is disclosed. Such therapies may be delivered by an implantable device and are useful in preventing the deleterious ventricular remodeling which occurs as a result of a heart attack or heart failure. The device may perform an assessment of cardiac function in order to individually modulate the delivery of the two types of therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.